Orvieto; Federica

Patent Applications and Registrations

Patent applications and USPTO patent grants for Orvieto; Federica.The latest application filed is for "antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors".

Company Profile

6.10.18

Orvieto; Federica - Pomezia IT
Orvieto; Federica - Rome IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antibody Peptide Conjugates That Have Agonist Activity At Both The Glucagon And Glucagon-like Peptide 1 Receptors App 20200392197 - Carrington; Paul E. ; et al.	2020-12-17
Long-acting Co-agonists Of The Glucagon And Glp-1 Receptors App 20200392196 - Palani; Anandan ; et al.	2020-12-17
Antibody peptide conjugates that have agonist activity at both the glucagon and glucagon-like peptide 1 receptors Grant 10,800,826 - Carrington , et al. October 13, 2	2020-10-13
Long-acting co-agonists of the glucagon and GLP-1 receptors Grant 10,793,615 - Palani , et al. October 6, 2	2020-10-06
Long-acting Co-agonists Of The Glucagon And Glp-1 Receptors App 20200270325 - Palani; Anandan ; et al.	2020-08-27
Long-acting Co-agonists Of The Glucagon And Glp-1 Receptors App 20190338008 - Palani; Anandan ; et al.	2019-11-07
Co-agonists of the glucagon and GLP-1 receptors Grant 10,413,593 - Bianchi , et al. Sept	2019-09-17
Insulin-incretin Conjugates App 20190175744 - Palani; Anandan ; et al.	2019-06-13
Antibody Peptide Conjugates That Have Agonist Activity At Both The Glucagon And Glucagon-like Peptide 1 Receptors App 20190071483 - Carrington; Paul ; et al.	2019-03-07
Co-agonists Of The Glucagon And Glp-1 Receptors App 20170360893 - Bianchi; Elisabetta ; et al.	2017-12-21
Co-agonists Of The Glucagon And Glp-1 Receptors App 20160114000 - Bianchi; Elisabetta ; et al.	2016-04-28
Amide Substituted Indazole And Benzotriazole Derivatives As Poly(adp-ribose)polymerase (parp) Inhibitors App 20110201657 - Boueres; Julia ; et al.	2011-08-18
Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors Grant 7,968,553 - Crescenzi , et al. June 28, 2	2011-06-28
N-substituted Hydroxypyrimidinone Carboxamide Inhibitors Of Hiv Integrase App 20110034449 - Crescenzi; Benedetta ; et al.	2011-02-10
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase Grant 7,820,660 - Crescenzi , et al. October 26, 2	2010-10-26
Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors App 20090275619 - Boueres; Julia ; et al.	2009-11-05
N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase App 20080275004 - Crescenzi; Benedetta ; et al.	2008-11-06
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase Grant 7,435,734 - Crescenzi , et al. October 14, 2	2008-10-14
Substituted pyrimido[1,2-a]azepines useful as HIV integrase inhibitors Grant 7,414,045 - Crescenzi , et al. August 19, 2	2008-08-19
Tetrahydro-4H-pyrido[1,2-a] pyrimidines useful as HIV integrase inhibitors App 20080176869 - Crescenzi; Benedetta ; et al.	2008-07-24
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase App 20070123524 - Crescenzi; Benedetta ; et al.	2007-05-31
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase Grant 7,217,713 - Crescenzi , et al. May 15, 2	2007-05-15
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase Grant 7,169,780 - Crescenzi , et al. January 30, 2	2007-01-30
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase App 20060258860 - Crescenzi; Benedetta ; et al.	2006-11-16
Tetrahydro--4h-pyrido[1,2-a}pyrimidines and related compounds useful as hiv integrase inhibitors App 20060046985 - Crescenzi; Benedetta ; et al.	2006-03-02
N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase App 20050025774 - Crescenzi, Benedetta ; et al.	2005-02-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.